Author:
Christakis Nicholas A.,Panner Morris J.
Abstract
On August 22, 1986, as part of its response to the AIDS epidemic, the Public Health Service (PHS) invited U.S. industrial firms to collaborate with the government in the development of an AIDS vaccine. The framework for the collaboration was outlined in a PHS document entitled, “AIDS Vaccine Development: Private Sector/Government Collaborative Efforts.” This document identified the resources the government is prepared to make available to industry, including patents, facilities, data, and assistance with clinical trials. The overall aim of the PHS proposal was to establish a formal framework for coordinating existing government and private efforts and to foster industry participation in the search for an AIDS vaccine.An example of private sector/government collaboration is provided in the human trial of an AIDS vaccine approved by the FDA in August 1987. The vaccine, named “VaxSyn HIV-1,“ is the product of a joint effort between a company called MicroGeneSys and investigators at the National Institute of Allergy and Infectious Disease (NIAID).
Publisher
Cambridge University Press (CUP)
Reference52 articles.
1. Polio, Politics, Publicity, and Duplicity: Ethical Aspects in the Development of the Salk Vaccine
2. 32. 49 Fed. Reg. 18900, at 18900.
3. “Development and Testing of AIDS Vaccines,”;Koff;Science,1988
4. 49. See Pollack, A. , “High Cost of High-Tech Drugs is Protested,” The New York Times, February 9, 1988, p. A1.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献